Follow-The-Filings

BEAM · Beam Therapeutics Inc.

Q1 2023 13F holders

← latest ownership dossier

Ticker
BEAM
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares